Dithiocarbamates effectively inhibit the α-carbonic anhydrase from Neisseria gonorrhoeae

References

• (a) Supuran CT. Bacterial carbonic anhydrases as drug targets: toward novel antibiotics? Front Pharmacol 2011;2:34. (b) Flaherty DP, Seleem MN, Supuran CT. Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets. Future Med Chem 2021;13:1619–22.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT, Capasso C. Antibacterial carbonic anhydrase inhibitors: an update on the recent literature. Expert Opin Ther Pat 2020;30:963–82.
   PubMed Web of Science ®Google Scholar
  (b) Campestre C, De Luca V, Carradori S, et al. Carbonic anhydrases: new perspectives on protein functional role and inhibition in Helicobacter pylori. Front Microbiol 2021;12:629163.
   PubMed Web of Science ®Google Scholar
  (c) Capasso C, Supuran CT. An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria? J Enzyme Inhib Med Chem 2015;30:325–32.
   PubMed Web of Science ®Google Scholar
  (d) Supuran CT, Capasso C. Biomedical applications of prokaryotic carbonic anhydrases. Expert Opin Ther Pat 2018; 28:745–54.
   PubMed Web of Science ®Google Scholar
• (a) Smith KS, Jakubzick C, Whittam TS, Ferry JG. Carbonic anhydrase is an ancient enzyme widespread in prokaryotes. Proc Natl Acad Sci USA 1999;96:15184–9.
   PubMed Web of Science ®Google Scholar
  (b). Abuaita BH, Withey JH. Bicarbonate induces Vibrio cholerae virulence gene expression by enhancing ToxT activity. Infect Immun 2009;77:4111–20.
   PubMed Web of Science ®Google Scholar
  (c) Merlin C, Masters M, McAteer S, Coulson A. Why is carbonic anhydrase essential to Escherichia coli? J Bacteriol 2003;185:6415–24.
   PubMed Web of Science ®Google Scholar
  (d) Del Prete S, Nocentini A, Supuran CT, Capasso C. Bacterial ι-carbonic anhydrase: a new active class of carbonic anhydrase identified in the genome of the Gram-negative bacterium Burkholderia territorii. J Enzyme Inhib Med Chem 2020;35:1060–8.
   PubMed Web of Science ®Google Scholar
• (a) Kaur J, Cao X, Abutaleb NS, et al. Optimization of acetazolamide-based scaffold as potent inhibitors of vancomycin-resistant enterococcus. J Med Chem 2020;63:9540–62.
   PubMed Web of Science ®Google Scholar
  (b) Abutaleb NS, Elkashif A, Flaherty DP, Seleem MN. In vivo antibacterial activity of acetazolamide. Antimicrob Agents Chemother 2021;65:e01715–20.
   PubMed Web of Science ®Google Scholar
  (c) Abutaleb NS, Elhassanny AEM, Flaherty DP, Seleem MN. In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci. PeerJ 2021;9:e11059.
   PubMed Web of Science ®Google Scholar
• (a) Hewitt CS, Abutaleb NS, Elhassanny AEM, et al. Structure-activity relationship studies of acetazolamide-based carbonic anhydrase inhibitors with activity against Neisseria gonorrhoeae. ACS Infect Dis 2021;7:1969–84.
   PubMed Web of Science ®Google Scholar
  (b) Nocentini A, Hewitt CS, Mastrolorenzo MD, et al. Anion inhibition studies of the α-carbonic anhydrases from Neisseria gonorrhoeae. J Enzyme Inhib Med Chem 2021;36:1061–6.
   PubMed Web of Science ®Google Scholar
• (a) Golparian D, Sánchez-Busó L, Cole M, Unemo M. Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance (NG-STAR) clonal complexes are consistent with genomic phylogeny and provide simple nomenclature, rapid visualization and antimicrobial resistance (AMR) lineage predictions. J Antimicrob Chemother 2021;76:940–4.
   PubMed Web of Science ®Google Scholar
  (b) Turner JM, Connolly KL, Aberman KE, et al. Molecular features of cephalosporins important for activity against antimicrobial-resistant Neisseria gonorrhoeae. ACS Infect Dis 2021;7:293–308.
   PubMed Web of Science ®Google Scholar
• (a) Yahara K, Ma KC, Mortimer TD, et al. Emergence and evolution of antimicrobial resistance genes and mutations in Neisseria gonorrhoeae. Genome Med 2021;13:51.
   PubMed Web of Science ®Google Scholar
  (b) Jacobsson S, Cole MJ, Spiteri G, on behalf of The Euro-GASP Network, et al. Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients’ gender, sexual orientation and anatomical site of infection, 2009–2016. BMC Infect Dis 2021;21:273.
   PubMed Web of Science ®Google Scholar
  (c) Aho EL, Ogle JM, Finck AM. The human microbiome as a focus of antibiotic discovery: Neisseria mucosa displays activity against Neisseria gonorrhoeae. Front Microbiol 2020;11:577762.
   PubMed Web of Science ®Google Scholar
• (a) Murray AB, Aggarwal M, Pinard M, et al. Structural mapping of anion inhibitors to β-carbonic anhydrase psCA3 from Pseudomonas aeruginosa. ChemMedChem 2018;13:2024–9.
   PubMed Web of Science ®Google Scholar
  (b) Pinard MA, Lotlikar SR, Boone CD, et al. Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa. Bioorg Med Chem 2015;23:4831–8.
   PubMed Web of Science ®Google Scholar
• (a) Matsumoto Y, Miyake K, Ozawa K, et al. Bicarbonate and unsaturated fatty acids enhance capsular polysaccharide synthesis gene expression in oral streptococci, Streptococcus anginosus. J Biosci Bioeng 2019;128:511–7.
   PubMed Web of Science ®Google Scholar
  (b) Capasso C, Supuran CT. An overview of the carbonic anhydrases from two pathogens of the oral cavity: Streptococcus mutans and Porphyromonas gingivalis. Curr Top Med Chem 2016;16:2359–68.
   PubMed Web of Science ®Google Scholar
  (c) Dedeoglu N, De Luca V, Isik S, et al. Cloning, characterization and anion inhibition study of a β-class carbonic anhydrase from the caries producing pathogen Streptococcus mutans. Bioorg Med Chem 2015;23:2995–3001.
   PubMed Web of Science ®Google Scholar
  (d) Burghout P, Vullo D, Scozzafava A, et al. Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives? Bioorg Med Chem 2011;19:243–8.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT. Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery. Expert Opin Drug Discov 2020;15:671–86.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008; 7:168–81.
   PubMed Web of Science ®Google Scholar
  (c) Mishra CB, Tiwari M, Supuran CT. Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today? Med Res Rev 2020;40:2485–565.
   PubMed Web of Science ®Google Scholar
• (a) De Simone G, Supuran CT. (In)organic anions as carbonic anhydrase inhibitors. J Inorg Biochem 2012; 111:117–29.
   PubMed Web of Science ®Google Scholar
  (b) Ozensoy Guler O, Capasso C, Supuran CT. A magnificent enzyme superfamily: carbonic anhydrases, their purification and characterization. J Enzym Inhib Med Chem 2016;31:689–94.
   PubMed Web of Science ®Google Scholar
  (c) Nocentini A, Angeli A, Carta F, et al. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J Enzyme Inhib Med Chem. 2021;36:561–80.
   PubMed Web of Science ®Google Scholar
  (d) Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759–72.
   PubMed Web of Science ®Google Scholar
  (e) Supuran CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem 2016;31:345–60.
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561–73.
   PubMed Web of Science ®Google Scholar
• (a) Petreni A, De Luca V, Scaloni A, et al. Anion inhibition studies of the Zn(II)-bound ι-carbonic anhydrase from the Gram-negative bacterium Burkholderia territorii. J Enzyme Inhib Med Chem 2021; 36:372–6.
   PubMed Web of Science ®Google Scholar
  (b) De Luca V, Petreni A, Nocentini A, et al. Effect of sulfonamides and their structurally related derivatives on the activity of ι -carbonic anhydrase from Burkholderia territorii. Int J Mol Sci 2021;22:571.
   PubMed Web of Science ®Google Scholar
• (a) Angeli A, Pinteala M, Maier SS, et al. Inhibition of α-, β-, γ-, δ-, ζ- and η-class carbonic anhydrases from bacteria, fungi, algae, diatoms and protozoans with famotidine. J Enzyme Inhib Med Chem 2019;34:644–50.
   PubMed Web of Science ®Google Scholar
  (b) Urbański LJ, Di Fiore A, Azizi L, et al. S. Biochemical and structural characterisation of a protozoan beta-carbonic anhydrase from Trichomonas vaginalis. J Enzyme Inhib Med Chem 2020;35:1292–9.
   PubMed Web of Science ®Google Scholar
• (a) Forkman A, Laurell AB. The effect of carbonic anhydrase inhibitor on the growth of Neisseriae. Acta Pathol Microbiol Scand 1965;65:450–6.
   PubMedGoogle Scholar
  (b) Nafi BM, Miles RJ, Butler LO, et al. Expression of carbonic anhydrase in neisseriae and other heterotrophic bacteria. J Med Microbiol 1990;32:1–7.
   PubMed Web of Science ®Google Scholar
• (a) Chirică LC, Elleby B, Jonsson BH, Lindskog S. The complete sequence, expression in Escherichia coli, purification and some properties of carbonic anhydrase from Neisseria gonorrhoeae. Eur J Biochem 1997;244:755–60.
   PubMedGoogle Scholar
  (b) Elleby B, Chirica LC, Tu C, et al. Characterization of carbonic anhydrase from Neisseria gonorrhoeae. Eur J Biochem 2001;268:1613–9.
   PubMedGoogle Scholar
• (a) Temperini C, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct--an inhibitor mimicking the sulfonamide and urea binding to the enzyme. Bioorg Med Chem Lett 2010;20:474–8.
   PubMed Web of Science ®Google Scholar
  (b) Innocenti A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of transmembrane isoforms IX, XII, and XIV with less investigated anions including trithiocarbonate and dithiocarbamate. Bioorg Med Chem Lett 2010;20:1548–50.
   PubMed Web of Science ®Google Scholar
• (a) Carta F, Aggarwal M, Maresca A, et al. Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations. Chem Commun 2012; 48:1868–70.
   PubMed Web of Science ®Google Scholar
  (b) Carta F, Aggarwal M, Maresca A, et al. Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo. J Med Chem 2012;55:1721–30.
   PubMed Web of Science ®Google Scholar
  (c) Syrjänen L, Tolvanen ME, Hilvo M, et al. Characterization, bioinformatic analysis and dithiocarbamate inhibition studies of two new α-carbonic anhydrases, CAH1 and CAH2, from the fruit fly Drosophila melanogaster. Bioorg Med Chem 2013;21:1516–21.
   PubMed Web of Science ®Google Scholar
• (a) Alhashimi M, Mayhoub A, Seleem MN. Repurposing salicylamide for combating multidrug-resistant Neisseria gonorrhoeae. Antimicrob Agents Chemother 2019;63:e01225–19.
   PubMed Web of Science ®Google Scholar
  (b) Seong YJ, Alhashimi M, Mayhoub A, et al. Repurposing fenamic acid drugs to combat multidrug-resistant Neisseria gonorrhoeae. Antimicrob Agents Chemother 2020;64:e02206–19.
   PubMed Web of Science ®Google Scholar
  (c) Elkashif A, Seleem MN. Investigation of auranofin and gold-containing analogues antibacterial activity against multidrug-resistant Neisseria gonorrhoeae. Sci Rep 2020;10:1–9.
   PubMed Web of Science ®Google Scholar
• (a) Vullo D, Durante M, Di Leva FS, et al. Monothiocarbamates strongly inhibit carbonic anhydrases in vitro and possess intraocular pressure lowering activity in an animal model of glaucoma. J Med Chem 2016; 59:5857–67.
   PubMed Web of Science ®Google Scholar
  (b) Carta F, Akdemir A, Scozzafava A, et al. Xanthates and trithiocarbonates strongly inhibit carbonic anhydrases and show antiglaucoma effects in vivo. J Med Chem 2013; 56:4691–700.
   PubMed Web of Science ®Google Scholar
• (a) Sanders E, Maren TH. Inhibition of carbonic anhydrase in Neisseria: effects on enzyme activity and growth. Mol Pharmacol 1967;3:204–15.
   PubMed Web of Science ®Google Scholar
  (b) Nafi BM, Miles RJ, Butler LO, et al. Expression of carbonic anhydrase in neisseriae and other heterotrophic bacteria. J Med Microbiol 1990;32:1–7.
   PubMed Web of Science ®Google Scholar
• Richter MF, Drown BS, Riley AP, et al. Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature 2017;545:299–304.
   PubMed Web of Science ®Google Scholar
• (a) Urbanski LJ, Bua S, Angeli A, et al. Sulphonamide inhibition profile of Staphylococcus aureus β-carbonic anhydrase. J Enzyme Inhib Med Chem 2020;35:1834–9.
   PubMed Web of Science ®Google Scholar
  (b) Fan SH, Ebner P, Reichert S, et al. MpsAB is important for Staphylococcus aureus virulence and growth at atmospheric CO2 levels. Nat Commun 2019;10:3627.
   PubMed Web of Science ®Google Scholar